QA: Endocyte INC in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001235007_2015_Endocyte_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001235007, Endocyte INC

  xvar xval
0 AssetsCurrent 127,038,338
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,970,665
3 remainder_Assets 81,792,371
4 LiabilitiesCurrent 6,884,996
5 LiabilitiesNoncurrent 30,316
6 remainder_Liabilities 881,944
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 23,677,366
9 ResearchAndDevelopmentExpense 41,649,389
10 remainder_Expenses 1,189
11 remainder_Revenues 70,353,483
12 remainder_NetIncome 433,938
13 remainder_ComprehensiveNetIncome -200,619
  yvar yval
0 Assets 212,801,374
1 Liabilities 7,797,256
2 Expenses 65,327,944
3 Revenues 70,353,483
4 StockholdersEquity 205,004,118
5 NetIncome 5,459,477
6 ComprehensiveNetIncome 5,359,168
7 BaseVar 178,457,307
8 EconomicCapitalRatiobeforeLimitedLiability 4.10
9 EconomicCapitalRatio 4.47

Edgar->Model Mapping

Feature Distribution

Change over Time